IDIQ for the purchase of consumables (multi-well plates) for use in Axion Biosystems Multielectrode Array systems

The Food and Drug Administration Office of Acquisition and Grant Services seeks an IDIQ contract for consumable multi-well plates for Axion Biosystems Multielectrode Array systems, with quotes due July 16, 2026, at 10:30 AM Central Time. The procurement is set aside exclusively for small business concerns.

Place of performance is the FDA Center for Drug Evaluation and Research in Silver Spring, Maryland. The IDIQ spans five one-year ordering periods from August 15, 2026, through August 14, 2031. The guaranteed minimum is $10,000 with an estimated ceiling of $349,000. The requirement covers ten line items of multi-well plates in 6-well, 12-well, 24-well, 48-well, and 96-well configurations, available in both black and white variants. Base-year quantities range from 1 to 10 units per item, with identical quantities for each subsequent ordering period. All shipping and handling must be included in unit pricing.

Plates must be newly manufactured and feature a minimum of 700 electrodes per plate, with real-time well-by-well signal review and temperature and electrical stimulation control capabilities. The plates must support automated cardiac and neural network analysis. Delivery is FOB Destination within 30 days of order receipt, with delivery prohibited during federal holidays. Payment terms are Net 30 days following government acceptance, with invoices submitted electronically through the Treasury Invoice Processing Platform. Pricing must be held firm through September 30, 2026. The NAICS code is 334516, Analytical Laboratory Instrument Manufacturing, with a size standard of 1,000 employees. Quotes should be submitted by email to Suzanne Martella at suzanne.martella@fda.hhs.gov.